bismuth citrate
Identification
| Name | bismuth citrate |
| IUPAC | bismuth;2-hydroxypropane-1,2,3-tricarboxylate |
| CAS Number | 813-93-4 |
| EINECS | 212-390-1 |
| FDA UNII | N04867Y76N |
| Molecular Formula | C6 H5 Bi O7 |
| Molecular Weight | 398.08065000 |
| MDL Number | MFCD00050817 |
| Nikkaji Number | J95.877H |
Regulatory
| FDA Mainterm (SATF) | Bismuth citrate |
| FDA Regulation | FDA PART 73-LISTING OF COLOR ADDITIVES EXEMPT FROM CERTIFICATION |
Physical Properties
| Assay | 95.00 to 100.00 |
| Food Chemicals Codex Listed | No |
| Boiling Point | 309.60 °C. @ 760.00 mm Hg (est) |
| Vapor Pressure | 0.000057 mmHg @ 25.00 °C. (est) |
| Flash Point | 311.00 °F. TCC ( 155.20 °C. ) (est) |
| logP (o/w) | -1.721 (est) |
Cosmetic Information
| CosIng | cosmetic data |
| Cosmetic Uses | buffering agents |
No sensory data available
Safety Information
| Preferred SDS | View |
| Oral/Parenteral Toxicity | Not determined |
| Dermal Toxicity | Not determined |
| Inhalation Toxicity | Not determined |
GHS Classification
['GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)', 'GHS Label elements, including precautionary statements']
Safety in Use
| Category | buffering agents, sequestrants |
| Recommendation for bismuth citrate usage levels up to | not for fragrance use. |
| Recommendation for bismuth citrate flavor usage levels up to | not for flavor use. |
American International Chemical, Inc.
Consistent sources
North American supplier for globally sourced ingredients.
BOC Sciences
Best of Chemicals Supplier
Quality supplier of research chemicals and biochemicals including inhibitors, building blocks, GMP Products, impurities and metabolites, APIs for Veterinary, Natural Compounds, ADCs, Stem Cell Molecul...
Penta International Corporation
Chemistry innovation
At Penta, our products and services help businesses do business better.
Potential Uses
Natural Occurrence
Synonyms
bismuth citrate USP
bismuth;2-hydroxypropane-1,2,3-tricarboxylate
PubMed:
Guidelines in the medical treatment of Helicobacter pylori infection.
PubMed:
Effect of oral administration of bismuth compounds on Campylobacter colonization in broilers.
PubMed:
Helicobacter pylori and early duodenal ulcer status post-treatment: a review.
PubMed:
Twice-daily versus thrice-daily clarithromycin in combination with ranitidine bismuth citrate in the eradication of Helicobacter pylori.
PubMed:
Treatment of H. pylori infection: the reality.
PubMed:
Effectiveness of ranitidine bismuth citrate, clarithromycin, and metronidazole therapy for treating Helicobacter pylori.
PubMed:
Ranitidine bismuth citrate in the treatment of Helicobacter pylori infection and duodenal ulcer.
PubMed:
Current FDA-approved treatments for Helicobacter pylori and the FDA approval process.
PubMed:
Guilty as charged: bugs and drugs in gastric ulcer.
PubMed:
Effects of ranitidine bismuth citrate on gastric acid secretion and gastrin release in subjects with and without Helicobacter pylori infection.
PubMed:
Effect of administration of ranitidine bismuth citrate with food on the suppression and eradication of Helicobacter pylori in infected volunteers.
PubMed:
Ranitidine bismuth citrate and ranitidine do not affect gastric emptying of a radio-labelled liquid meal.
PubMed:
Effect of ranitidine bismuth citrate on postprandial plasma gastrin and pepsinogens.